Karen L Reckamp (Karen Reckamp)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Joel W Neal, Katherine Minichiello, Ryan C Brennick, Richard S P Huang, Matthew C Hiemenz, Cornel Amler, Jyoti Patel, Roy S Herbst, Karen L Reckamp, Hossein Borghaei, Louise Highleyman, Mary W Redman, Lincoln W Pasquina, David E Kozono
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol. The oncologist 29 (6) (2024)
Joel W Neal, Katherine Minichiello, Ryan C Brennick, Richard S P Huang, Matthew C Hiemenz, Cornel Amler, Jyoti Patel, Roy S Herbst, Karen L Reckamp, Hossein Borghaei, Louise Highleyman, Mary W Redman, Lincoln W Pasquina, David E Kozono
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol. The oncologist 29 (6) (2024)
Joel W Neal, Katherine Minichiello, Ryan C Brennick, Richard S P Huang, Matthew C Hiemenz, Cornel Amler, Jyoti Patel, Roy S Herbst, Karen L Reckamp, Hossein Borghaei, Louise Highleyman, Mary W Redman, Lincoln W Pasquina, David E Kozono
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol. The oncologist 29 (6) (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Joel W Neal, Katherine Minichiello, Ryan C Brennick, Richard S P Huang, Matthew C Hiemenz, Cornel Amler, Jyoti Patel, Roy S Herbst, Karen L Reckamp, Hossein Borghaei, Louise Highleyman, Mary W Redman, Lincoln W Pasquina, David E Kozono
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol. The oncologist (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, Brian S Henick, Wade T Iams, Charles D Blanke, Roy S Herbst, Jhanelle E Gray, Karen L Reckamp
Pragmaticism in Cancer Clinical Trials. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Helena Alexandra Yu, Yasushi Goto, Hidetoshi Hayashi, Enriqueta Felip Font, James Chih-Hsin Yang, Martin Reck, Kiyotaka Yoh, Se-Hoon Lee, Luis G Paz-Ares, Benjamin Besse, Paolo Bironzo, Dong Wan Kim, Melissa Lynne Johnson, Yi-Long Wu, Thomas John, Steven Kao, Toshiyuki Kozuki, Erminia Massarelli, Jyoti D Patel, Egbert F Smit, Karen L Reckamp, Qian Dong, Pomy Shrestha, Pang-Dian Fan, Parul Patel, Andrea Sporchia, David W Sternberg, Dalila Sellami, Pasi A Janne
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ryan D Gentzler, Nisha A Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser H Hanna, Young Kwang Chae, Marianna Koczywas, Irene B Helenowski, Jyoti D Patel
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175. The oncologist (2023)
Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Stephen Kay, Laura J Walton, Junwu Shen, Sanjay Popat, D Ross Camidge
Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L. Current medical research and opinion 38 (9) (2022)
Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highleyman, Vassiliki Papadimitrakopoulou, Joel W Neal, Saiama N Waqar, Jyoti D Patel, Jhanelle E Gray, David R Gandara, Karen Kelly, Roy S Herbst
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Laura J Walton, Stephen Kay, Allie Cichewicz, Binod Neupane, Kyle Fahrbach, Sanjay Popat, D Ross Camidge
Indirect comparisons of brigatinib and alectinib for front-line ALK -positive non-small-cell lung cancer. Future oncology (London, England) 18 (20) (2022)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Bing Liu, Daniela Duenas, Li Zheng, Karen L Reckamp, Binghui Shen
Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer. Protein & cell (2021)
Loretta Ehrunmwunsee, Sam E Wing, Jenny Shen, Hengrui Hu, Ernesto Sosa, Lisa N Lopez, Catherine Raquel, Melissa Sur, Pilar Ibarra-Noriega, Madeline Currey, Janet Lee, Jae Y Kim, Dan J Raz, Arya Amini, Sagus Sampath, Marianna Koczywas, Erminia Massarelli, Howard L West, Karen L Reckamp, Rick A Kittles, Ravi Salgia, Victoria L Seewaldt, Susan L Neuhausen, Stacy W Gray
The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (8) (2021)
Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, Nathalie Nguyen, Laurel J Finster, Joslyn Foley, Justin Darrah, Jun Gong, Ronald Paquette, Alain C Mita, Robert Vescio, Inderjit Mehmi, Reva Basho, Warren G Tourtellotte, Carissa A Huynh, Gil Y Melmed, Jonathan G Braun, Dermot Pb McGovern, Emebet Mengesha, Greg Botwin, John C Prostko, Edwin C Frias, James L Stewart, Sandy Joung, Jennifer Van Eyk, Joseph E Ebinger, Susan Cheng, Kimia Sobhani, Karen L Reckamp, Akil Merchant
Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients. Cancer research (2021)
Karen L Reckamp, Jasmine A McQuerry, Isa Mambetsariev, Rebecca R Pharaon, Susan E Yost, Jeremy Fricke, Tamara Mirzapoiazova, Raju K Pillai, Ziad Khan, Marwan G Fakih, Yuan Yuan, Marianna Koczywas, Erminia Massarelli, Prakash Kulkarni, Sumanta Kumar Pal, Martin Sattler, Andrea Bild, Ravi Salgia
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations. Future science OA 7 (2) (2020)
Leora Horn, Jeffrey R Infante, Karen L Reckamp, George R Blumenschein, Ticiana A Leal, Saiama N Waqar, Barbara J Gitlitz, Rachel E Sanborn, Jennifer G Whisenant, Liping Du, Joel W Neal, Jon P Gockerman, Gary Dukart, Kimberly Harrow, Chris Liang, James J Gibbons, Allison Holzhausen, Christine M Lovly, Heather A Wakelee
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (12) (2018)
James H Suh, Alexa B Schrock, Adrienne Johnson, Doron Lipson, Laurie M Gay, Shakti Ramkissoon, Jo-Anne Vergilio, Julia A Elvin, Abdur Shakir, Peter Ruehlman, Karen L Reckamp, Sai-Hong Ignatius Ou, Jeffrey S Ross, Philip J Stephens, Vincent A Miller, Siraj M Ali
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing. The oncologist 23 (7) (2018)
Long Gu, Robert Lingeman, Fumiko Yakushijin, Emily Sun, Qi Cui, Jianfei Chao, Weidong Hu, Hongzhi Li, Robert J Hickey, Jeremy M Stark, Yate-Ching Yuan, Yuan Chen, Steven L Vonderfecht, Timothy W Synold, Yanhong Shi, Karen L Reckamp, David Horne, Linda H Malkas
The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (23) (2018)
Alexander E Drilon, Siqing Fu, Manish R Patel, Marwan Fakih, Ding Wang, Anthony J Olszanski, Daniel Morgensztern, Stephen V Liu, Byoung Chul Cho, Lyudmila Bazhenova, Cristina P Rodriguez, Robert C Doebele, Antoinette Wozniak, Karen L Reckamp, Tara Seery, Petros Nikolinakos, Zheyi Hu, Jennifer W Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S Multani, Myung-Ju Ahn
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105. Cancer discovery 9 (3) (2018)